Insights
Professional
Practice
Industry
Region
Trending Topics
Location
Type
Sort by:
Firm News 6 results
Firm News | 1 min read | 01.27.25
Crowell Represents Iron Health in Acquisition by Metronomic
San Fransisco – Jan. 27, 2024: A Crowell team successfully advised Iron Health in its acquisition by digital health startup Metronomic. Iron Health was founded over two years ago with an important mission: partner with OB/GYNs to address gaps in women’s health care through innovation. Since its founding, Iron Health built a novel model of care that provides accessible, equitable, quality women’s health care through a virtual care technology platform and multidisciplinary care team— all knitted into the trusted relationship women have with their OB/GYN. Through a strong track record of commercial partnerships across six states, Iron Health was able to provide access to more than 1 million women in the form of 4,000 patient visits, including behavioral health, weight management, nutrition, gestational diabetes, primary care, and menopause services.
Firm News | 1 min read | 11.22.24
Crowell & Moring Represents Anitian in Successful $7M Series D Funding
San Francisco - November 22, 2024: Crowell & Moring advised Anitian, a leading provider of compliance automation solutions, on a $7 million Series D funding, led by Sageview Capital and with participation by Forgepoint Capital. This funding enables Anitian to accelerate the development of new innovations, including AI-driven automation features and an accredited Platform-as-a-Service (PaaS). Together, these features reduce the time and cost of achieving FedRAMP and CMMC compliance for Cloud Service Providers (CSPs) and the Defense Industrial Base (DIB). The most recent financing brings Anitian’s total funding to more than $50 million.
Firm News | 1 min read | 11.08.24
San Francisco – November 8, 2024: Marshall Wace led Inquis Medical’s oversubscribed $40 million Series B round, along with participation from existing investors, including ShangBay Capital, Yu Star, EnPointe Ventures, and Pierre Lamond.